PlainRecalls
FDA Drug Low Class III Terminated

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

Reported: May 29, 2013 Initiated: April 19, 2013 #D-420-2013

Product Description

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

Details

Recalling Firm
Novartis Consumer Health
Units Affected
3,828 Tubes
Distribution
Nationwide
Location
Lincoln, NE

Frequently Asked Questions

What product was recalled?
Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85. Recalled by Novartis Consumer Health. Units affected: 3,828 Tubes.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 29, 2013. Severity: Low. Recall number: D-420-2013.